Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001140361-26-035375 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
600,000
Total Value
$7,923,392.58
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President&Immunovant CEO | Common Shares | โ | Aug 28, 2026 | Exercise/Conversion | 200,000 | $3.85 | $770,000.00 | 1,799,154 | Direct | โ | View Details | |
President&Immunovant CEO | Common Shares | โ | Aug 28, 2026 | Sale | 166,182 | $35.63 | $5,921,064.66 | 1,632,972 | Direct | โ | View Details | |
President&Immunovant CEO | Common Shares | โ | Aug 28, 2026 | Sale | 33,818 | $36.44 | $1,232,327.92 | 1,599,154 | Direct | โ | View Details | |
President&Immunovant CEO | Stock Option (Right to Buy) | Derivative | Aug 28, 2026 | Exercise/Conversion | 200,000 | $0.00 | $0.00 | 3,844,834 | Direct | โ | View Details |